These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26829425)

  • 41. Totally drug-resistant tuberculosis in India.
    Udwadia ZF; Amale RA; Ajbani KK; Rodrigues C
    Clin Infect Dis; 2012 Feb; 54(4):579-81. PubMed ID: 22190562
    [No Abstract]   [Full Text] [Related]  

  • 42. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 43. Adduct Formation of Delamanid with NAD in Mycobacteria.
    Hayashi M; Nishiyama A; Kitamoto R; Tateishi Y; Osada-Oka M; Nishiuchi Y; Kaboso SA; Chen X; Fujiwara M; Inoue Y; Kawano Y; Kawasaki M; Abe T; Sato T; Kaneko K; Itoh K; Matsumoto S; Matsumoto M
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotypic diversity of multidrug-, quinolone- and extensively drug-resistant Mycobacterium tuberculosis isolates in Thailand.
    Disratthakit A; Meada S; Prammananan T; Thaipisuttikul I; Doi N; Chaiprasert A
    Infect Genet Evol; 2015 Jun; 32():432-9. PubMed ID: 25847698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine.
    Wallis RS
    Eur Respir J; 2016 Nov; 48(5):1526-1527. PubMed ID: 27799400
    [No Abstract]   [Full Text] [Related]  

  • 46. Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine.
    Tadolini M; Lingtsang RD; Tiberi S; Enwerem M; D'Ambrosio L; Sadutshang TD; Centis R; Migliori GB
    Eur Respir J; 2016 Nov; 48(5):1527-1529. PubMed ID: 27799401
    [No Abstract]   [Full Text] [Related]  

  • 47. Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
    Tasneen R; Betoudji F; Tyagi S; Li SY; Williams K; Converse PJ; Dartois V; Yang T; Mendel CM; Mdluli KE; Nuermberger EL
    Antimicrob Agents Chemother; 2016 Jan; 60(1):270-7. PubMed ID: 26503656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bedaquiline.
    Goulooze SC; Cohen AF; Rissmann R
    Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China.
    He W; Liu C; Liu D; Ma A; Song Y; He P; Bao J; Li Y; Zhao B; Fan J; Cheng Q; Zhao Y
    J Glob Antimicrob Resist; 2021 Sep; 26():241-248. PubMed ID: 34214699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timing is everything for compassionate use of delamanid.
    Barry CE
    Nat Med; 2015 Mar; 21(3):211. PubMed ID: 25742452
    [No Abstract]   [Full Text] [Related]  

  • 51. Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.
    Ajbani K; Rodrigues C; Shenai S; Mehta A
    J Clin Microbiol; 2011 Apr; 49(4):1588-90. PubMed ID: 21289142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unraveling Dilemmas and Lacunae in the Escalating Drug Resistance of
    Negi A; Perveen S; Gupta R; Singh PP; Sharma R
    J Med Chem; 2024 Feb; 67(4):2264-2286. PubMed ID: 38351709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
    Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A
    Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China.
    Zhang J; Mi L; Wang Y; Liu P; Liang H; Huang Y; Lv B; Yuan L
    BMC Res Notes; 2012 Jun; 5():309. PubMed ID: 22713520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neoteric advancement in TB drugs and an overview on the anti-tubercular role of peptides through computational approaches.
    Khusro A; Aarti C; Barbabosa-Pliego A; Salem AZM
    Microb Pathog; 2018 Jan; 114():80-89. PubMed ID: 29174699
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Yu X; Gao X; Li C; Luo J; Wen S; Zhang T; Ma Y; Dong L; Wang F; Huang H
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis.
    Mohr E; Ferlazzo G; Hewison C; De Azevedo V; Isaakidis P
    Lancet Infect Dis; 2019 May; 19(5):470. PubMed ID: 31034392
    [No Abstract]   [Full Text] [Related]  

  • 58. No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.
    Pang Y; Jing W; Lu J; Zong Z; Huo F; Dong L; Dai G; Li Y; Huang H; Chu N
    Diagn Microbiol Infect Dis; 2019 Aug; 94(4):361-364. PubMed ID: 30876684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration.
    Stinson K; Kurepina N; Venter A; Fujiwara M; Kawasaki M; Timm J; Shashkina E; Kreiswirth BN; Liu Y; Matsumoto M; Geiter L
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3316-22. PubMed ID: 26976868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.
    Battaglia S; Spitaleri A; Cabibbe AM; Meehan CJ; Utpatel C; Ismail N; Tahseen S; Skrahina A; Alikhanova N; Mostofa Kamal SM; Barbova A; Niemann S; Groenheit R; Dean AS; Zignol M; Rigouts L; Cirillo DM
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32907992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.